Audentes Therapeutics Inc
BOLD · Chemicals & Drugs · NASDAQ · in our data July 20, 2016 to January 14, 2020 (3.5 years)
The first trading day in our data for Audentes Therapeutics Inc is July 20, 2016 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on January 6, 2020, the market valued it at $2.7 billion. It left the market when it was bought or merged, last trading at $59.97, -0.1% from its split-adjusted high. Holders got whatever the deal paid, which is not in our price data.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 2016.
Could you have seen it coming? Play COVIDAlso gone in 2020: Chemicals & Drugs
- Avon Products peaked at $21.8 billion
- Immunomedics Inc peaked at $20.3 billion
- Myokardia Inc peaked at $12.0 billion
- Medicines Co (the) peaked at $6.8 billion
- Akorn Inc peaked at $6.4 billion
- PDL Biopharma Inc peaked at $6.3 billion
